Brief: Cumberland Pharmaceuticals Posts Q3 Loss Per Share Of $0.07
09/11/2021 23:01
Nov 9 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS & COMPANY UPDATE
* Q3 LOSS PER SHARE $0.07
* Q3 REVENUE $8.1 MILLION VERSUS $9.3 MILLION
Source text for Eikon: ID:nPn7SBtBZa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM